Fernandez-Cejas, Esther

Link to this page

Authority KeyName Variants
7a86bb5c-1da9-4020-ac24-33caacac3538
  • Fernandez-Cejas, Esther (1)
Projects
No records found.

Author's Bibliography

Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban

Gomez-Moreno, Gerardo; Aguilar-Salvatierra, Antonio; Fernandez-Cejas, Esther; Arcesio Delgado-Ruiz, Rafael; Marković, Aleksa; Calvo Guirado, Jose Luis

(Wiley, Hoboken, 2016)

TY  - JOUR
AU  - Gomez-Moreno, Gerardo
AU  - Aguilar-Salvatierra, Antonio
AU  - Fernandez-Cejas, Esther
AU  - Arcesio Delgado-Ruiz, Rafael
AU  - Marković, Aleksa
AU  - Calvo Guirado, Jose Luis
PY  - 2016
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2088
AB  - Objectives: The aim of this study was to evaluate the incidence of bleeding complications after dental implant placement in patients in treatment by the anticoagulant oral rivaroxaban without interrupting its administration or modifying dosage. Materials and methods: About 57 patients were divided into two groups: 18 had been in treatment by rivaroxaban for over 6 month before implant surgery and a control group consisted of 39 healthy subjects. All subjects received dental implants in different positions, without interrupting or modifying rivaroxaban dosage. Patients were treated in an outpatient setting. Non-absorbable sutures were used, and all patients were given gauze impregnated with tranexamic acid 5%, to bite on for 30 60 min. Results: One rivaroxaban patient presented moderate bleeding the day after surgery, and two control patients presented moderate bleeding the day after and on the second day. Bleeding was managed with gauzes impregnated with tranexamic acid. No statistically significant differences (P 0.688) were found in relation to bleeding episodes between the groups, with a relative risk 0.919 based on the pooled groups and 95% confidence interval of 0.078 10.844. Conclusions: Dental implant surgery in patients taking the anticoagulant oral rivaroxaban can be performed safely in outpatients departments applying local hemostatic measures without the need to modify or interrupt anticoagulant medication.
PB  - Wiley, Hoboken
T2  - Clinical Oral Implants Research
T1  - Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban
VL  - 27
IS  - 6
SP  - 730
EP  - 733
DO  - 10.1111/clr.12653
ER  - 
@article{
author = "Gomez-Moreno, Gerardo and Aguilar-Salvatierra, Antonio and Fernandez-Cejas, Esther and Arcesio Delgado-Ruiz, Rafael and Marković, Aleksa and Calvo Guirado, Jose Luis",
year = "2016",
abstract = "Objectives: The aim of this study was to evaluate the incidence of bleeding complications after dental implant placement in patients in treatment by the anticoagulant oral rivaroxaban without interrupting its administration or modifying dosage. Materials and methods: About 57 patients were divided into two groups: 18 had been in treatment by rivaroxaban for over 6 month before implant surgery and a control group consisted of 39 healthy subjects. All subjects received dental implants in different positions, without interrupting or modifying rivaroxaban dosage. Patients were treated in an outpatient setting. Non-absorbable sutures were used, and all patients were given gauze impregnated with tranexamic acid 5%, to bite on for 30 60 min. Results: One rivaroxaban patient presented moderate bleeding the day after surgery, and two control patients presented moderate bleeding the day after and on the second day. Bleeding was managed with gauzes impregnated with tranexamic acid. No statistically significant differences (P 0.688) were found in relation to bleeding episodes between the groups, with a relative risk 0.919 based on the pooled groups and 95% confidence interval of 0.078 10.844. Conclusions: Dental implant surgery in patients taking the anticoagulant oral rivaroxaban can be performed safely in outpatients departments applying local hemostatic measures without the need to modify or interrupt anticoagulant medication.",
publisher = "Wiley, Hoboken",
journal = "Clinical Oral Implants Research",
title = "Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban",
volume = "27",
number = "6",
pages = "730-733",
doi = "10.1111/clr.12653"
}
Gomez-Moreno, G., Aguilar-Salvatierra, A., Fernandez-Cejas, E., Arcesio Delgado-Ruiz, R., Marković, A.,& Calvo Guirado, J. L.. (2016). Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban. in Clinical Oral Implants Research
Wiley, Hoboken., 27(6), 730-733.
https://doi.org/10.1111/clr.12653
Gomez-Moreno G, Aguilar-Salvatierra A, Fernandez-Cejas E, Arcesio Delgado-Ruiz R, Marković A, Calvo Guirado JL. Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban. in Clinical Oral Implants Research. 2016;27(6):730-733.
doi:10.1111/clr.12653 .
Gomez-Moreno, Gerardo, Aguilar-Salvatierra, Antonio, Fernandez-Cejas, Esther, Arcesio Delgado-Ruiz, Rafael, Marković, Aleksa, Calvo Guirado, Jose Luis, "Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban" in Clinical Oral Implants Research, 27, no. 6 (2016):730-733,
https://doi.org/10.1111/clr.12653 . .
2
49
27
44